Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Valvular Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 200 articles:
HTML format



Single Articles


    July 2025
  1. ALHAKAK A, Butt JH, Havers-Borgersen E, Ostergaard L, et al
    Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study.
    Eur Heart J. 2025 Jul 11:ehaf342. doi: 10.1093.
    PubMed     Abstract available


  2. GIACOPPO D
    Unveiling the risk of infective endocarditis after mitral valve replacement and mitral valve repair.
    Eur Heart J. 2025 Jul 11:ehaf099. doi: 10.1093.
    PubMed    


  3. KANEKO T, Kagiyama N, Okazaki S, Amano M, et al
    Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries.
    Eur Heart J. 2025 Jul 9:ehaf511. doi: 10.1093.
    PubMed     Abstract available


  4. LIU H, Fang Y, Cheng W
    Traumatic interventricular septal dissection in a bicuspid aortic valve patient: a rare extension into the left ventricle.
    Eur Heart J. 2025 Jul 4:ehaf499. doi: 10.1093.
    PubMed    


  5. BLITZER D, Meinrenken CJ, Apelgren NB, Chavez XS, et al
    Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures.
    Eur Heart J. 2025 Jul 2:ehaf379. doi: 10.1093.
    PubMed     Abstract available


    June 2025
  6. YANG WL, Hu BY
    Giant ascending aortic aneurysm in a 6-year-old boy with LOX gene mutation associated with familial thoracic aortic aneurysm type 10.
    Eur Heart J. 2025 Jun 24:ehaf402. doi: 10.1093.
    PubMed    


  7. CREA F
    Focus on juvenile hypertension, deep learning-qualified body composition for risk stratification, infective endocarditis, and mixed valvular heart disease.
    Eur Heart J. 2025;46:2249-2252.
    PubMed    


  8. COMPAGNONE M, Windecker S, Dall'Ara G, Galvani M, et al
    Great debate: Transcatheter aortic valve implantation should also be performed in non-surgical centres.
    Eur Heart J. 2025 Jun 5:ehaf363. doi: 10.1093.
    PubMed    


  9. NITSCHE C, Dobner S, Rosenblum HR, Patel KP, et al
    Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis.
    Eur Heart J. 2025 Jun 2:ehaf362. doi: 10.1093.
    PubMed     Abstract available


    May 2025
  10. BASU J, Nikoletou D, Miles C, MacLachlan H, et al
    High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial.
    Eur Heart J. 2025;46:1803-1815.
    PubMed     Abstract available


  11. ISHIKAWA E, Kageyama S
    Acquired von Willebrand syndrome caused by paravalvular prosthetic mitral regurgitation.
    Eur Heart J. 2025 May 13:ehaf334. doi: 10.1093.
    PubMed    


  12. BARBANTI M, Costa G, Windecker S, Maisano F, et al
    Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation.
    Eur Heart J. 2025 May 9:ehaf307. doi: 10.1093.
    PubMed     Abstract available


  13. PEDICINO D, Liuzzo G
    Weekly Journal Scan: does dapagliflozin expand the therapeutic options after transcatheter aortic valve implantation?
    Eur Heart J. 2025 May 6:ehaf309. doi: 10.1093.
    PubMed    


  14. LIN S, Zhang H, Li Z
    Quadricuspid aortic valve with partial left coronary sinus isolation.
    Eur Heart J. 2025 May 2:ehaf252. doi: 10.1093.
    PubMed    


    April 2025
  15. VAN KAMPEN A, Levine RA, Borger MA
    Is mitral annular disjunction the cause of arrhythmogenic mitral valve prolapse?
    Eur Heart J. 2025 Apr 24:ehaf264. doi: 10.1093.
    PubMed    


  16. COISNE A, Lancellotti P, Cote N, Ternacle J, et al
    Blood biomarkers in left-sided valvular heart disease.
    Eur Heart J. 2025 Apr 22:ehaf232. doi: 10.1093.
    PubMed     Abstract available


  17. LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al
    Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery.
    Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093.
    PubMed     Abstract available


  18. ZITO F, Rhellab R, de Keijzer AR
    Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all.
    Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093.
    PubMed    


  19. PATEL KP, Baumbach A
    Clinical implications of sex-related differences in severe aortic stenosis.
    Eur Heart J. 2025 Apr 8:ehaf199. doi: 10.1093.
    PubMed    


  20. TCHETCHE D, Pibarot P, Bax JJ, Bonaros N, et al
    Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
    Eur Heart J. 2025 Apr 2:ehaf133. doi: 10.1093.
    PubMed     Abstract available


    March 2025
  21. LONG A, Finer J, Hartman H, Hartzel D, et al
    Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-Regurgitation study.
    Eur Heart J. 2025 Mar 29:ehaf248. doi: 10.1093.
    PubMed     Abstract available


  22. CHEN M, Michel J, Kasel AM
    26 mm SAPIEN fractured 23 mm SAPIEN and surgical prosthesis: a transcatheter aortic valve-in-valve-in-valve implantation.
    Eur Heart J. 2025 Mar 29:ehaf173. doi: 10.1093.
    PubMed    


  23. INDOLFI C, Esposito G, Luscher TF
    TAVI or TAVR: it is time to use a single standardized acronym for percutaneous aortic valve implantation.
    Eur Heart J. 2025 Mar 13:ehaf048. doi: 10.1093.
    PubMed    


    February 2025
  24. MOCUMBI A
    European Society of Cardiology guidelines for the management of valvular heart disease: should we apply these to rheumatic heart disease?
    Eur Heart J. 2025 Feb 28:ehae641. doi: 10.1093.
    PubMed    


  25. UNGER P, Galloo X, Pibarot P
    Mixed valvular heart disease: diagnosis and management.
    Eur Heart J. 2025 Feb 27:ehaf116. doi: 10.1093.
    PubMed     Abstract available


  26. BAUMGARTNER H, Iung B, Messika-Zeitoun D
    The Year in Cardiovascular Medicine 2024: the top 10 papers in valvular heart disease.
    Eur Heart J. 2025 Feb 27:ehaf071. doi: 10.1093.
    PubMed    


  27. PEDICINO D, Vergallo R
    Weekly Journal Scan: is transcatheter replacement therapy for tricuspid regurgitation ready for prime time?
    Eur Heart J. 2025 Feb 19:ehaf060. doi: 10.1093.
    PubMed    


  28. SPRINGHETTI P, Abdoun K, Dumont E, Dagenais F, et al
    Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes.
    Eur Heart J. 2025 Feb 18:ehaf076. doi: 10.1093.
    PubMed     Abstract available


  29. DE PAULIS R, Chirichilli I, de Kerchove L, Della Corte A, et al
    Current status of aortic valve repair surgery.
    Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093.
    PubMed     Abstract available


  30. VERGALLO R, Pedicino D
    Weekly Journal Scan: transcatheter vs. surgical treatment of combined severe aortic valve stenosis and obstructive coronary artery disease.
    Eur Heart J. 2025 Feb 14:ehaf023. doi: 10.1093.
    PubMed    


  31. CREA F
    Focus on aortic stenosis prevention and mitral regurgitation diagnosis.
    Eur Heart J. 2025;46:595-597.
    PubMed    


  32. ABDELHAMID M, Abdel Meged AM, Prendergast B, Calvo-Iglesias FE, et al
    Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2025 Feb 11:ehaf050. doi: 10.1093.
    PubMed     Abstract available


  33. ANGELLOTTI D, Praz F, Windecker S
    Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge repair: a complex interplay.
    Eur Heart J. 2025 Feb 10:ehaf044. doi: 10.1093.
    PubMed    


    January 2025
  34. MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al
    Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
    Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093.
    PubMed     Abstract available


  35. LURZ P, Zancanaro E, Kresoja KP
    Personalized management of tricuspid valve regurgitation.
    Eur Heart J. 2025 Jan 11:ehae733. doi: 10.1093.
    PubMed    


  36. AARTS HM, Voskuil M, Delewi R
    Coronary revascularization in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: is it time to bridge the gap?
    Eur Heart J. 2025 Jan 9:ehae762. doi: 10.1093.
    PubMed    


    December 2024
  37. ANG DTY, Lindsay MM
    Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation.
    Eur Heart J. 2024 Dec 23:ehae876. doi: 10.1093.
    PubMed    


  38. GARCIA-PAVIA P, Oreziak A, Masri A, Barriales-Villa R, et al
    Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2024;45:5071-5083.
    PubMed     Abstract available


  39. VERGALLO R, Pedicino D
    Weekly Journal Scan: Pushing the boundaries of transcatheter aortic valve implantation in asymptomatic patients with severe aortic stenosis.
    Eur Heart J. 2024 Dec 11:ehae839. doi: 10.1093.
    PubMed    


  40. SUN Y, Wang Z, Qian Y
    What's the relationship between secondary mitral regurgitation and secondary tricuspid regurgitation in atrial fibrillation patients and how to treat them?
    Eur Heart J. 2024 Dec 4:ehae815. doi: 10.1093.
    PubMed    


  41. NASER JA, Siontis KC, Nkomo VT
    The steps towards understanding tricuspid regurgitation: one 'careful' step at a time and many more 'careful' steps needed.
    Eur Heart J. 2024 Dec 4:ehae816. doi: 10.1093.
    PubMed    


  42. HALLE M, Wernhart S, Krane M
    Exercise in primary, secondary and tertiary prevention of aortic stenosis.
    Eur Heart J. 2024 Dec 4:ehae627. doi: 10.1093.
    PubMed    


  43. BLASER MC, Back M, Luscher TF, Aikawa E, et al
    Calcific aortic stenosis: omics-based target discovery and therapy development.
    Eur Heart J. 2024 Dec 4:ehae829. doi: 10.1093.
    PubMed     Abstract available


    November 2024
  44. GARG P, Pavon AG, Penicka M, Uretsky S, et al
    Cardiovascular magnetic resonance imaging in mitral valve disease.
    Eur Heart J. 2024 Nov 20:ehae801. doi: 10.1093.
    PubMed     Abstract available


  45. LI Z, Xiang D, Hu K
    Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure.
    Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093.
    PubMed    


  46. VERGALLO R, Pedicino D
    Weekly Journal Scan: Should we treat obstructive coronary artery disease in patients undergoing transcatheter aortic valve implantation?
    Eur Heart J. 2024 Nov 12:ehae761. doi: 10.1093.
    PubMed    


  47. COATS CJ, Masri A, Barriales-Villa R, Abraham TP, et al
    Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
    Eur Heart J. 2024;45:4464-4478.
    PubMed     Abstract available


  48. CREA F
    Evolving therapeutic approaches to aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, and acute heart failure.
    Eur Heart J. 2024;45:4451-4455.
    PubMed    


    October 2024
  49. RHEUDE T, Ruge H, Altaner N, Pellegrini C, et al
    Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial.
    Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093.
    PubMed     Abstract available


  50. PEDICINO D, Vergallo R
    Weekly Journal Scan: RESHAPing potential treatment indications for functional mitral regurgitation in heart failure.
    Eur Heart J. 2024 Oct 29:ehae727. doi: 10.1093.
    PubMed    


  51. PEDICINO D, Vergallo R
    Weekly Journal Scan: is MATTERHORN a game changer for secondary mitral regurgitation? Still climbing.
    Eur Heart J. 2024 Oct 11:ehae650. doi: 10.1093.
    PubMed    


  52. DE CATERINA R, Ten Cate H, Pengo V
    Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging.
    Eur Heart J. 2024 Oct 8:ehae615. doi: 10.1093.
    PubMed    


  53. LANCELLOTTI P, Go YY, Vannan MA
    Unveiling sex differences in valvular disease care and outcomes.
    Eur Heart J. 2024;45:3834-3836.
    PubMed    


    September 2024
  54. TALHA KM, Metra M, Butler J
    Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation.
    Eur Heart J. 2024 Sep 9:ehae544. doi: 10.1093.
    PubMed    


  55. SCHOFER N, Blankenberg S
    Transfemoral or surgical aortic valve replacement in young low-risk patients with tricuspid and bicuspid aortic valve stenosis.
    Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093.
    PubMed    


  56. SATO M, Yoshijima N, Yashima F
    Sinus sequestration due to transcatheter heart valve endothelialization after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093.
    PubMed    


  57. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    PubMed    


  58. ACKERMANN P, Abdel-Wahab M, Noack T
    Macroscopic findings of severe structural valve deterioration of a transcatheter aortic bioprosthesis.
    Eur Heart J. 2024;45:3092.
    PubMed    


  59. MARTINSSON A, Jeppsson A
    Invited editorial on "Outcome of aortic valve replacement versus conservative treatment in asymptomatic patients with severe aortic stenosis - Five years follow-up of the AVATAR randomized controlled trial" by Banovic et al.
    Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093.
    PubMed    


  60. BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al
    Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial.
    Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093.
    PubMed     Abstract available


    August 2024
  61. BONAROS N, Gollmann-Tepekoylu C, Grimm M
    Tricuspid valve trilogy: between risks and timing for surgery.
    Eur Heart J. 2024 Aug 30:ehae562. doi: 10.1093.
    PubMed    


  62. DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al
    Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE.
    Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093.
    PubMed     Abstract available


  63. MASCHERBAUER J, Kammerlander A, Nitsche C, Bax J, et al
    Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.
    Eur Heart J. 2024 Aug 30:ehae523. doi: 10.1093.
    PubMed     Abstract available


  64. NOTENBOOM ML, de Keijzer AR, Veen KM, Gokalp A, et al
    Sex-related differences in the clinical course of aortic root and ascending aortic aneurysms: the DisSEXion Study.
    Eur Heart J. 2024 Aug 26:ehae525. doi: 10.1093.
    PubMed     Abstract available


  65. BAI L, Feng Y, Chen M
    A very rare complication of transcatheter aortic valve replacement.
    Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093.
    PubMed    


  66. MACH F, Miteva K
    Window of opportunity for developing effective medical intervention for calcific aortic valve disease.
    Eur Heart J. 2024 Aug 12:ehae426. doi: 10.1093.
    PubMed    


  67. LOPES LR, Ho CY, Elliott PM
    Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.
    Eur Heart J. 2024;45:2727-2734.
    PubMed     Abstract available


    July 2024
  68. WANG J, Hu P, Ma XJ
    Mechanical mitral valve obstruction: gone with the wind.
    Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093.
    PubMed    


  69. GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S
    Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery.
    Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093.
    PubMed    


  70. BERNARD A, Deharo P, Fauchier L
    Time matters when considering treatment for patients with mitral regurgitation.
    Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093.
    PubMed    


  71. CREA F
    A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
    Eur Heart J. 2024;45:2267-2270.
    PubMed    


  72. ARSENOS P, Tsioufis K, Gatzoulis KA
    Programmed ventricular stimulation for risk stratification in hypertrophic cardiomyopathy patients.
    Eur Heart J. 2024;45:2341-2342.
    PubMed    


  73. HUANG Y, Wang C, Zhou T, Xie F, et al
    Lumican promotes calcific aortic valve disease through H3 histone lactylation.
    Eur Heart J. 2024 Jul 8:ehae407. doi: 10.1093.
    PubMed     Abstract available


  74. MURARU D, Badano LP
    Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
    Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
    PubMed    


  75. JAHANYAR J, de Kerchove L, El Khoury G
    Forme fruste unicuspid aortic valves.
    Eur Heart J. 2024 Jul 3:ehae432. doi: 10.1093.
    PubMed    


  76. THYREGOD HGH, De Backer O, Sondergaard L
    A notion of bioprosthetic aortic valve durability.
    Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093.
    PubMed    


  77. LI Z, Cheng S, Guo B, Ding L, et al
    Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis.
    Eur Heart J. 2024 Jul 2:ehae406. doi: 10.1093.
    PubMed     Abstract available


  78. BEKKI M, Tahara N, Fukumoto Y
    Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
    Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
    PubMed    


  79. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is there still a question to be answered?
    Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093.
    PubMed    


  80. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
    Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
    Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
    PubMed     Abstract available


    June 2024
  81. HAHN RT
    Sex-related differences in degenerative mitral regurgitation: a call to action.
    Eur Heart J. 2024 Jun 13:ehae360. doi: 10.1093.
    PubMed    


  82. ZHUANG Y, Wang W, Lu F
    Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral cervical approach.
    Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093.
    PubMed    


  83. CREA F
    Optimizing the treatment of severe aortic stenosis.
    Eur Heart J. 2024;45:1861-1865.
    PubMed    


  84. VERGALLO R, Pedicino D
    Weekly Journal Scan: transcatheter aortic valve implantation in patients with small aortic annulus.
    Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093.
    PubMed    


    May 2024
  85. ELTCHANINOFF H, Durand E
    Transfemoral aortic valve implantation and concomitant CAD: the jury is out.
    Eur Heart J. 2024 May 31:ehae141. doi: 10.1093.
    PubMed    


  86. WANG J, Chen X, Zhao S
    Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
    Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
    PubMed    



  87. Correction to: Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 May 27:ehae144. doi: 10.1093.
    PubMed    


  88. AVIERINOS JF, Tribouilloy C, Bursi F, Grigioni F, et al
    Degenerative mitral regurgitation due to flail leaflet: sex-related differences in presentation, management, and outcomes.
    Eur Heart J. 2024 May 16:ehae265. doi: 10.1093.
    PubMed     Abstract available


  89. DVIR D, Tchetche D, Leon MB, Genereux P, et al
    Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
    Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
    PubMed     Abstract available


  90. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
    Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
    Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
    PubMed     Abstract available


  91. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
    Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
    Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
    PubMed     Abstract available


  92. ZEPPENFELD K, de Riva M
    Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
    Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
    PubMed    


    April 2024
  93. PIBAROT P
    Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
    Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
    PubMed    


  94. PIERONI M, Namdar M, Olivotto I, Desnick RJ, et al
    Anderson-Fabry disease management: role of the cardiologist.
    Eur Heart J. 2024;45:1395-1409.
    PubMed     Abstract available


  95. KASKI JP, Norrish G, Gimeno Blanes JR, Charron P, et al
    Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
    Eur Heart J. 2024;45:1443-1454.
    PubMed     Abstract available


  96. TAHARA N, Fukumoto Y, Tayama E
    Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission tomography/computed tomography to assess left ventricular workload in obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2024;45:1488.
    PubMed    


  97. BLEIZIFFER S
    Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
    Eur Heart J. 2024;45:1125-1126.
    PubMed    


    March 2024
  98. FRANK D, Durand E, Lauck S, Muir DF, et al
    A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
    Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
    PubMed     Abstract available



  99. Correction to: Tricuspid valve disease and cardiac implantable electronic devices.
    Eur Heart J. 2024 Mar 29:ehae221. doi: 10.1093.
    PubMed    


  100. BAKAR SN, Ong G, Fam NP
    LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
    Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
    PubMed    



  101. Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
    Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
    PubMed    


  102. CREA F
    Mitral, aortic, and tricuspid valve disease: new light shed on mechanisms, risk stratification, and treatment optimization.
    Eur Heart J. 2024;45:857-860.
    PubMed    


  103. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
    Great debate: symptomatic moderate aortic stenosis should undergo intervention.
    Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
    PubMed    


  104. MARTINSSON A, Rasalingam R, Jeppsson A
    Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
    Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
    PubMed    


  105. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    PubMed    


  106. MURARU D, Badano LP, Hahn RT, Lang RM, et al
    Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
    Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
    PubMed     Abstract available


  107. MEHILLI J
    Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
    Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
    PubMed    


  108. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
    Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
    PubMed     Abstract available


  109. MCGREGOR M, Bews H, Jassal DS
    Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place.
    Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093.
    PubMed    


  110. MAISANO F, Hahn R, Sorajja P, Praz F, et al
    Transcatheter treatment of the tricuspid valve: current status and perspectives.
    Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
    PubMed     Abstract available


    February 2024
  111. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    PubMed    


  112. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
    The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
    Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
    PubMed    


  113. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    PubMed    


  114. LUDWIG S, Granada JF
    Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
    Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
    PubMed    


  115. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    PubMed     Abstract available


  116. CREA F
    The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity.
    Eur Heart J. 2024;45:317-320.
    PubMed    


    January 2024
  117. THORNTON GD, Vassiliou VS, Musa TA, Aziminia N, et al
    Myocardial Scar and Remodelling Predict Long-Term Mortality in Severe Aortic Stenosis Beyond 10 Years.
    Eur Heart J. 2024 Jan 25:ehae067. doi: 10.1093.
    PubMed    


  118. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
    Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
    PubMed     Abstract available


  119. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    PubMed     Abstract available


  120. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
    Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
    PubMed     Abstract available


  121. NAKAMURA K, Taniguchi T, Furukawa Y
    Haemolytic anaemia after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
    PubMed    


  122. LI Z, Zhang H, Lin S
    Functionally bicuspid aortic valve leads to myocardial ischaemia.
    Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
    PubMed    


  123. LONG X, Deng S, Liu W, Bu J, et al
    Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study.
    Eur Heart J. 2024;45:233-235.
    PubMed    


  124. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
    Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
    Eur Heart J. 2024;45:198-210.
    PubMed     Abstract available


  125. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
    Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
    PubMed     Abstract available


  126. KADDOURA R, Al-Hijji M
    The evolution of transcatheter valvular interventions: current evidence.
    Eur Heart J. 2024;45:10-14.
    PubMed    


    December 2023
  127. ALLOUBA M, Walsh R, Afify A, Hosny M, et al
    Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:5146-5158.
    PubMed     Abstract available


  128. INGLES J, MacArthur DG
    The moral and practical urgency of increasing diversity in genomics.
    Eur Heart J. 2023;44:5157-5159.
    PubMed    


  129. ANDREAS M, Burri H, Praz F, Soliman O, et al
    Tricuspid valve disease and cardiac implantable electronic devices.
    Eur Heart J. 2023 Dec 14:ehad783. doi: 10.1093.
    PubMed     Abstract available


  130. PIRIOU PG, Plessis J, Guerin P
    Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
    Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
    PubMed    


  131. GRANI C
    Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4793-4795.
    PubMed    


  132. WANG J, Yang S, Ma X, Zhao K, et al
    Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
    Eur Heart J. 2023;44:4781-4792.
    PubMed     Abstract available


    November 2023
  133. VERGALLO R, Volpe M
    Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
    Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
    PubMed    


  134. LU ZN, Yang Y, Song G
    A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
    Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
    PubMed    


  135. BRAUNWALD E, Saberi S, Abraham TP, Elliott PM, et al
    Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:4622-4633.
    PubMed     Abstract available


  136. TOMII D, Praz F, Windecker S
    Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
    Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
    PubMed    


  137. CREA F
    Hot topics in valvular heart disease: tricuspid regurgitation, bicuspid aortic valve, artificial intelligence for aortic stenosis, and aortic aneurysm.
    Eur Heart J. 2023;44:4493-4496.
    PubMed    


  138. PATEL KP, Baumbach A
    Timing treatment for tricuspid regurgitation.
    Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
    PubMed    


  139. WERT L, Falk V, Potapov EV
    Severe aortic regurgitation after short-term treatment with microaxial left ventricular assist device in the transaxillary approach.
    Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093.
    PubMed    


  140. IDHREES M, Kumar A, Velayudhan B
    'Paravalvular leak' after Bentall's procedure, yet not a paravalvular leak.
    Eur Heart J. 2023;44:4392.
    PubMed    


  141. KODALI S, Hahn RT, Makkar R, Makar M, et al
    Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
    Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
    PubMed     Abstract available


    October 2023
  142. HARARI E, Landes U
    Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
    Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
    PubMed    


  143. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
    Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
    Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
    PubMed    


  144. DE BACKER J, Prakash SK
    Refining the course: long-term outcome in patients with bicuspid aortic valve.
    Eur Heart J. 2023 Oct 4:ehad621. doi: 10.1093.
    PubMed    


  145. FARJAT-PASOS JI, Dumont E, Paradis JM
    Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
    Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
    PubMed    


  146. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
    Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
    Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
    PubMed     Abstract available


  147. WEISSLER-SNIR A, Rakowski H, Meyer M
    Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?
    Eur Heart J. 2023;44:3655-3657.
    PubMed    


  148. DEVRIES JH, Irs A, Hillege HL
    The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.
    Eur Heart J. 2023;44:3492-3494.
    PubMed    


    September 2023
  149. CHHABRA ST, Takkar A, Arya RC
    An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'.
    Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093.
    PubMed    


  150. BEYGUI F, Guillemot V, Saloux E
    Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
    Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
    PubMed    


  151. MOORE JP, Aboulhosn JA, Khairy P
    Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
    Eur Heart J. 2023;44:3228-3230.
    PubMed    


  152. CREA F
    TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
    Eur Heart J. 2023;44:3105-3109.
    PubMed    


  153. FENG S, Wu F, Pan X
    Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
    Eur Heart J. 2023;44:3199.
    PubMed    


    August 2023
  154. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
    Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
    Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
    PubMed     Abstract available


  155. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
    TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
    Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
    PubMed     Abstract available


  156. YANG LT, Ye Z, Wajih Ullah M, Maleszewski JJ, et al
    Bicuspid aortic valve: long-term morbidity and mortality.
    Eur Heart J. 2023 Aug 23:ehad477. doi: 10.1093.
    PubMed     Abstract available


  157. HOLSTE G, Oikonomou EK, Mortazavi BJ, Coppi A, et al
    Severe aortic stenosis detection by deep learning applied to echocardiography.
    Eur Heart J. 2023 Aug 23:ehad456. doi: 10.1093.
    PubMed     Abstract available


  158. VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al
    End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study.
    Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093.
    PubMed     Abstract available


  159. PRENDERGAST BD, Patterson T, Redwood S
    Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
    Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
    PubMed    


  160. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
    Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
    Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
    PubMed     Abstract available


  161. AL ZAIDI M, Nickenig G, Zimmer S
    Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
    Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
    PubMed    


  162. EIROS R, Gallego-Delgado M, Villacorta E
    Unravelling an hypertrophic myocardiopathy.
    Eur Heart J. 2023;44:2788.
    PubMed    


    July 2023
  163. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
    Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
    Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
    PubMed    


  164. WALDSCHMIDT L, Seiffert M
    Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?
    Eur Heart J. 2023 Jul 5:ehad277. doi: 10.1093.
    PubMed    


  165. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
    Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
    Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
    PubMed     Abstract available


  166. LORENZATTI D, Pina P, Slipczuk L
    Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
    Eur Heart J. 2023;44:2350.
    PubMed    


    June 2023
  167. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
    Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
    Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
    PubMed     Abstract available


  168. GOEL K, Shah P, Jones BM, Korngold E, et al
    Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
    PubMed     Abstract available



  169. Corrigendum to: MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Jun 21:ehad407. doi: 10.1093.
    PubMed    


  170. TAKANO R, Tsuji A, Ogo T
    A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia after palliative surgery.
    Eur Heart J. 2023 Jun 17:ehad402. doi: 10.1093.
    PubMed    


  171. PEDICINO D, Vergallo R
    Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
    Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
    PubMed    


  172. BRAY JJH, Freer R, Pitcher A, Kharbanda R, et al
    Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis.
    Eur Heart J. 2023 Jun 8:ehad320. doi: 10.1093.
    PubMed     Abstract available


  173. EVANGELISTA A, Michelena HI
    Family screening for bicuspid aortic valve: indicated, but easy to implement?
    Eur Heart J. 2023 Jun 8:ehad057. doi: 10.1093.
    PubMed    


  174. CREA F
    Understanding aortic stenosis: advances in the identification of actionable pharmacological targets.
    Eur Heart J. 2023;44:1847-1850.
    PubMed    


    May 2023
  175. LORENZINI M, Elliott PM
    Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
    Eur Heart J. 2023;44:1519-1521.
    PubMed    


  176. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
    Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
    Eur Heart J. 2023;44:1530-1540.
    PubMed     Abstract available


    April 2023
  177. BUTCHER SC, Essayagh B, Enriquez-Sarano M
    Rescue surgery for degenerative mitral regurgitation should be recognized for what it is: indispensable but imperfect.
    Eur Heart J. 2023 Apr 28:ehad242. doi: 10.1093.
    PubMed    


  178. DANDEL M
    Degenerative mitral regurgitation: improving clinical decision-making and risk stratification before valve surgery or trans-catheter repair.
    Eur Heart J. 2023 Apr 28:ehad216. doi: 10.1093.
    PubMed    


  179. LI Y, He Q, Xie M
    A rare case of papillary muscle rupture caused by percutaneous balloon mitral valvuloplasty.
    Eur Heart J. 2023 Apr 26:ehad254. doi: 10.1093.
    PubMed    


  180. LEE J, Kim JS, Shim CY
    MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
    Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
    PubMed    


  181. PEDICINO D, Vergallo R
    Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
    Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
    PubMed    


  182. ORRINGER CE
    C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander?
    Eur Heart J. 2023;44:1461-1463.
    PubMed    


  183. THERIAULT S, Mathieu P, Bosse Y
    The journey towards identification of actionable molecular pathways in calcific aortic valve stenosis.
    Eur Heart J. 2023 Apr 12:ehad134. doi: 10.1093.
    PubMed    


  184. CHEN HY, Dina C, Small AM, Shaffer CM, et al
    Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.
    Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093.
    PubMed     Abstract available


  185. SEQUEIRA V, Batzner A, Maack C
    Targeting mitochondria in hypertrophic cardiomyopathy.
    Eur Heart J. 2023;44:1186-1188.
    PubMed    


  186. NOLLET EE, Duursma I, Rozenbaum A, Eggelbusch M, et al
    Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.
    Eur Heart J. 2023;44:1170-1185.
    PubMed     Abstract available


    March 2023
  187. KAGASE A, Yamamoto M, Tokuda T
    Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
    Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
    PubMed    


  188. XIE Z, Zhu H
    A rare case of mitral regurgitation caused by primary aldosteronism.
    Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
    PubMed    


  189. CHEN YH, Chang HH, Leu HB
    Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
    Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
    PubMed    


  190. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
    Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
    Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
    PubMed     Abstract available


  191. CHORIN E, Topilsky Y
    The synergy between tricuspid regurgitation and machine learning.
    Eur Heart J. 2023 Mar 17:ehad140. doi: 10.1093.
    PubMed    


  192. RAO VN, Giczewska A, Chiswell K, Felker GM, et al
    Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
    Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093.
    PubMed     Abstract available


  193. MESSIKA-ZEITOUN D, Baumgartner H, Burwash IG, Vahanian A, et al
    Unmet needs in valvular heart disease.
    Eur Heart J. 2023 Mar 16:ehad121. doi: 10.1093.
    PubMed     Abstract available


  194. CHUNG CJ, Otto CM
    Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
    Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
    PubMed    


  195. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
    Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
    Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
    PubMed     Abstract available


  196. CREA F
    Spotlight on aortic stenosis and dissection: mechanisms, management, and new therapeutic targets.
    Eur Heart J. 2023;44:783-787.
    PubMed    


  197. RODES-CABAU J, Nuche J
    Are contemporary TAVI results influenced by hospital volume?
    Eur Heart J. 2023;44:868-870.
    PubMed    


  198. CHEN J, Yang Y, Wei L
    One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
    Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
    PubMed    


  199. KEMALOGLU OZ T, Badano LP
    Can three-dimensional echocardiography change the game for the pulmonary valve?
    Eur Heart J. 2023;44:703-705.
    PubMed    


    October 2021
  200. ELLIOTT P
    Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.
    Eur Heart J. 2021;42:3945-3947.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.